0.6522

0.91% 0.0059

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $0.6522, with a volume of 213.27K. It is up +0.91% in the last 24 hours and down -26.23% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Previous Close:

$0.6463

Open:

$0.633

24h Volume:

213.27K

Relative Volume:

0.06

Market Cap:

$256.00M

Revenue:

$86.26M

Net Income/Loss:

$-50.08M

P/E Ratio:

-2.6631

EPS:

-0.2449

Net Cash Flow:

$-94.48M

1W Performance:

-8.45%

1M Performance:

-26.23%

6M Performance:

-42.28%

1Y Performance:

-45.65%

1-Day Range:

$0.6301

$0.6697

1-Week Range:

$0.6301

$0.7199

52-Week Range:

$0.6301

$1.72

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1084)

Industry

Medical Devices (140)

Phone

(650) 266-6000

Address

50 MILK STREET, BOSTON

Employee

389

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB Standard Biotools Inc	0.6521	263.66M	86.26M	-50.08M	-94.48M	-0.2449
ABT Abbott Laboratories	115.73	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	329.36	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.61	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.87	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.91	53.19B	6.30B	1.07B	1.09B	1.8406

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-25	Downgrade	TD Cowen	Buy → Hold
Feb-27-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-16-24	Initiated	TD Cowen	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

03:19 AM

Enterprise value to EBIT forward of Standard BioTools Inc. – BX:FLB - TradingView

03:19 AM

Aug 20, 2026

Long Focus Capital Management, LLC Adds to Standard BioTools Inc - GuruFocus

Aug 20, 2026

Aug 16, 2026

Standard BioTools (LAB) Slides 4.99% to $0.71 as Selling Pressure PersistsFactor Valuation - Vinanet

Aug 16, 2026

Aug 14, 2026

Standard BioTools (LAB) holders report 7.3% stake in amended ownership filing - Stock Titan

Aug 14, 2026

Standard BioTools Inc.: Target Price Consensus and Analysts Recommendations | LAB | US34385P1084 - marketscreener.com

Aug 14, 2026

Standard BioTools (LAB): Long Focus Capital discloses 23.5M shares, 6% passive stake - Stock Titan

Aug 14, 2026

Aug 11, 2026

Standard BioTools (LAB) Short Interest & Short Float | Updated Aug 2026 $LAB - MarketBeat

Aug 11, 2026

Aug 09, 2026